Table 2. Survey results.
| correct | incorrect | I don’t know | missing | |
| Inheritance risk | 31 (56%) | 13 (23%) | 9 (16%) | 3 (5%) |
| Frequency of sexual dysfunctions | 14 (25%) | 28 (50%) | 13 (23%) | 1 (2%) |
| IMT before conception (female patients) | 28 (50%) | 19 (34%) | 6 (11%) | 3 (5%) |
| IMT before conception (male patients) | 36 (64%) | 8 (14%) | 11 (20%) | 1 (2%) |
| Escalation therapy before conception | 14 (25%) | 6 (11%) | 11 (20%) | 8 (14%) |
| Relapse rate during pregnancy | 47 (84%) | 3 (5%) | 5 (9%) | 1 (2%) |
| Complications during pregnancy | 42 (75%) | 7 (13%) | 5 (9%) | 2 (3%) |
| Relapse treatment during pregnancy | 26 (46%) | 18 (32%) | 11 (20%) | 1 (2%) |
| Assisted delivery | 15 (27%) | 11 (19%) | 29 (52%) | 1 (2%) |
| Peridural anaesthesie | 41 (73%) | 4 (7%) | 10 (18%) | 1 (2%) |
| Pregnancy outcome | 35 (63%) | 9 (16%) | 10 (18%) | 2 (3%) |
| Post partum relapse rate | 37 (66%) | 8 (14%) | 8 (14%) | 3 (5%) |
| Breast feeding | 17 (31%) | 27 (48%) | 9 (16%) | 3 (5%) |
| IMT post partum | 33 (59%) | 8 (14%) | 7 (13%) | 8 (14%) |
| Influence of pregnancies on longterm MS course | 35 (63%) | 3 (5%) | 14 (25%) | 4 (7%) |
| Assisted reproductive technique | 12 (21%) | 14 (25%) | 26 (47%) | 4 (7%) |
IMT: immunomodulatory therapy.